- Home
- BIO vs S Comparison
BIO vs S Comparison
Compare BIO & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- S
- Stock Information
- Founded
- BIO 1952
- S 2013
- Country
- BIO United States
- S United States
- Employees
- BIO N/A
- S N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- S EDP Services
- Sector
- BIO Industrials
- S Technology
- Exchange
- BIO Nasdaq
- S Nasdaq
- Market Cap
- BIO 6.0B
- S 5.9B
- IPO Year
- BIO N/A
- S 2021
- Fundamental
- Price
- BIO $257.04
- S $17.30
- Analyst Decision
- BIO Strong Buy
- S Buy
- Analyst Count
- BIO 4
- S 29
- Target Price
- BIO $324.25
- S $24.83
- AVG Volume (30 Days)
- BIO 374.5K
- S 6.0M
- Earning Date
- BIO 07-31-2025
- S 08-26-2025
- Dividend Yield
- BIO N/A
- S N/A
- EPS Growth
- BIO N/A
- S N/A
- EPS
- BIO N/A
- S N/A
- Revenue
- BIO $2,541,100,000.00
- S $864,135,000.00
- Revenue This Year
- BIO N/A
- S $24.05
- Revenue Next Year
- BIO $3.49
- S $20.71
- P/E Ratio
- BIO N/A
- S N/A
- Revenue Growth
- BIO N/A
- S 28.19
- 52 Week Low
- BIO $211.43
- S $15.36
- 52 Week High
- BIO $387.99
- S $29.29
- Technical
- Relative Strength Index (RSI)
- BIO 65.41
- S 39.64
- Support Level
- BIO $245.87
- S $18.15
- Resistance Level
- BIO $264.68
- S $18.81
- Average True Range (ATR)
- BIO 7.34
- S 0.52
- MACD
- BIO 1.84
- S 0.01
- Stochastic Oscillator
- BIO 78.94
- S 18.11
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.